ARTICLE | Company News
Ace BioSciences, Program for Appropriate Technology in Health infectious news
June 23, 2008 7:00 AM UTC
Ace will receive $5 million over two years from the not-for-profit PATH to develop Ace’s ACE527 (formerly ACE537) vaccine to prevent diarrhea caused by enterotoxigenic Escherichia coli (ETEC). PATH ...